All events occur at the Gaylord National Resort & Convention Center, unless otherwise noted. Schedule is subject to change.

B1: Simulation: Applications for the Practicing Vascular Surgeon: Where We Came From, Where We Are, and How Far Should We Go?

 

At the end of this session, participants should be able to: 

1. Discuss the increasing role of simulation training in the vascular surgical curriculum.
2. Explain how simulation can be used to prepare for complex endovascular cases.
3. Describe the role of simulation in technical and non-technical skills assessment and how simulation may be used in Board certification and maintenance of certification.
4. Identify centers providing simulation training and courses offered.
5. Relate the limitations to simulation.

Moderators: Anil P. Hingorani MD, Lutheran Medical Center, Brooklyn, NY
Erica L. Mitchell MD, Oregon Health & Science University, Portland, OR
    
6:30 am
Introduction

 

6:35 am
Simulation: Enhancing Resident Training
John F. Eidt MD, University of Arkansas for Medical Sciences, Little Rock, AR

 

6:45 am
Simulation: Patient Specific Applications for the Practicing Surgeon
Karl A. Illig MD, University of South Florida, Tampa, FL

 

6:55 am
Simulation for Board Certification & MOC
Peter F. Lawrence MD, UCLA Medical Center, Los Angeles, CA

 

Debate

 

7:05 am
Simulation: The Way of the Future
Alan B. Lumsden, MD, The Methodist DeBakey Heart and Vascular Center, Houston, TX

 

7:15 am
Simulation: It’s Just a Waste of Time
Michel S. Makaroun MD, University of Pittsburgh Medical Center, Pittsburgh, PA

 

7:25 am
Rebuttals

 

7:30 am

Panel Discussion

B2: Next Steps in Carotid Stenting
Room: Maryland C

 

At the end of this session, participants should be able to:

1. Review recent United States carotid artery stent trial results.
2. Compare imaging methods and describe their utility for predicting stroke hazard.
3. Discuss potential advantages and disadvantages of embolic protection strategies.
4. Describe the sensitivity of MRI for cerebral ischemic events.
5. Evaluate clinical trial endpoints in carotid intervention.

Moderators: Jon S. Matsumura MD, University of Wisconsin School of Medicine and Public Health, Madison, WI
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI

 

6:30 am
Preprocedure Carotid Plaque Characterization Will Help Us Select the Right Patients: TCD, GSM, IVUS, VH
Carlos H. Timaran MD, University of Texas, Dallas, TX

 

6:45 am
Recent US CAS Data that Helps Us Understand Where the Whole Field is Going
Jon S. Matsumura MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

 

7:00 am
Now that We Have Alternatives to Distal Filter EP, How Will We Select the Right Embolic Protection to Reduce Stroke Risk?
Daniel G. Clair MD, The Cleveland Clinic, Cleveland, OH

 

7:15 am
MRI Infarcts: Useful Surrogate or Overly Sensitive Marker?
Sumaira Macdonald MBChB (Comm) FRCR FRCP PhD EBIR, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom

 

7:30 am
MI: Diluting Composite Endpoint or Important Primary Outcome?
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI

 

7:45 am
Discussion

B3: Advanced Embolization
Room: Maryland D

 

At the end of this session, participants should be able to:

1. Describe the techniques used in and the indications for the embolization of type 2 endoleaks following EVAR.
2. Describe the techniques used in and the indications for embolization of AVMs.
3. Describe the techniques used in and the indications for uterine artery embolization for fibroids.
4. Describe the techniques used in and the indications for embolization in the setting of traumatic injuries.

Moderators:Marc E. Mitchell MD, University of Mississippi Medical Center, Jackson, MS
Richard F. Neville, MD, George Washington University Medical Center, Washington, DC

 

6:30 am
Advanced Techniques for Treatment of Type II Endoleaks
Ross Milner MD, University of Chicago Medical Center, Chicago, IL

 

6:40 am
Arterial Embolization for Trauma
Zachary K. Baldwin MD, University of Mississippi Medical Center, Jackson, MS

 

6:50 am
Uterine Artery Embolization
Carlos H. Timaran MD, University of Texas, Dallas, TX

 

7:00 am
Embolization of AVMs
Cynthia K. Shortell MD, Duke University Medical Center, Durham, NC

 

7:10 am
Panel Discussion 

6:30 am – 8:00 am            Medical Student Program Breakfast
                                         Room: Potomac 4-6

8:00 am – 8:20 am            Opening Ceremony
                                         Room: Potomac A/B
                                         Presiding: Richard P. Cambria MD, Massachusetts General Hospital, Boston, MA

8:20 am – 9:50 am            S1: William J. von Liebig Forum
                                         Room: Potomac A/B

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
2. Identify new technology for diagnosis and treatment of vascular disease.

Moderators:Richard P. Cambria MD, Massachusetts General Hospital, Boston, MA
Ronald M. Fairman MD, Hospital of the University of Pennsylvania, Philadelphia, PA

8:20 am
SS1. Impact of Transfusion and Nadir Postoperative Hemoglobin on Short- and Long-term Outcomes After Interventions for Peripheral Arterial Disease (PAD)
Panos Kougias¹, Sonia Orcutt², Peter H. Lin², George Pisimisis¹, Neal R. Barshes¹, Carlos F. Bechara^1
1Michael E. DeBakey VAMC, Houston, TX; ²Baylor College of Medicine, Houston, TX.

8:34 am
SS2. The Impact of Arterial Pedal Arch Quality and Angiosome Revascularization on the Outcome of Distal Bypass Surgery
Hani Slim, Hany Zayed, Michael Edmonds, Hisham Rashid
Vascular Surgery, King's Collage Hospital, London, United Kingdom.

8:48 am
Video Presentation
VS1. Ultrasound for the Diagnosis and Treatment of Popliteal Entrapment Syndrome
Marlin W. Causey, Thomas Curry, Reagan Quan, Charles Andersen, Niten Singh
Madigan Army Medical Center, Ft. Lewis, WA.

8:58 am
SS3. Infrapopliteal Angioplasty for Critical Limb Ischemia: Results at 5-year Follow-up
Ruby C. Lo, Rodney P. Bensley, Kristina A. Giles, Jeremy D. Darling, Mark Wyers, Allen D. Hamdan, Elliot Chaikof, Marc L. Schermerhorn
Beth Israel Deaconess Medical Center, Boston, MA.

9:12 am
SS4. Patient-centered Outcomes Following Endovascular Intervention for Critical Limb Ischemia
Javier E. Anaya-Ayala, Christopher J. Smolock, Charudatta S. Bavare, Mitul S. Patel, Hosam F. El-Sayed, Jean Bismuth, Eric K. Peden, Alan Lumsden, Mark G. Davies
Cardiovascular Surgery, Methodist DeBakey Heart & Vascular Center, Houston, TX.

9:26 am
SVS FOUNDATION RESIDENT RESEARCH PRIZE PAPER
SS5. A Novel Mouse Model of Hind Limb Ischemia to Test Therapeutic Angiogenesis
Robert Brenes², Caroline C. Jadlowiec¹, Mackenzie Bear¹, Peter Hashim¹, Clinton D. Protack¹, Xin Li¹, Wei Lv¹, Michael J. Collins¹, Alan Dardik^1
1Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, CT; ²Saint Mary's Hospital, The Stanley J. Dudrick Department of Surgery, Waterbury, CT.

Critical Issues in Venous Disease

 

At the end of this session, participants should be able to:

1. Identify current practices in the management of acute and venous disease.
2. Explain the current role and future prospects of vascular surgeons in the treatment of venous disease.
3. Explain challenges and opportunities of free standing vein clinics and multidisciplinary vein centers.
4. Discuss credentialing vein centers.
5. Explain FDA requirements on management of IVC filters.
6. Relate the SVS initiatives to increase public and physician awareness in venous disease and improve education of venous specialists. 

Moderator: Peter Gloviczki MD, Mayo Clinic, Rochester, MN

10:20 am
Vascular Surgeons Need to Stay Leaders in the Management of Chronic Venous Disease 
Thomas F. O’Donnell, Jr. MD, Tufts Medical Center, Boston, MA

10:28 am
Vascular Surgeons Need to Become Leaders in the Management of Acute Venous Disease 
Robert B. McLafferty MD, Southern Illinois University School of Medicine, Springfield, IL

10:36 am
SVS Membership Survey on Venous Disease
Ruth L. Bush MD, Scott and White Memorial Hospital, Temple, TX

10:44 am
Training and Credentialing of Venous Disease
Michael C. Dalsing MD, Indiana University School of Medicine, Indianapolis, IN

10:52 am
Opportunities and Challenges of Practice in Free-standing Vein Clinics
Jose I. Almeida MD RVT, Miami Vein Center, Miami, FL

11:00 am
Opportunities and Challenges of Practice in Multidisciplinary Vein Centers
Cynthia K. Shortell MD, Duke University Medical Center, Durham, NC

11:08 am
Credentialing of Vein Clinics
Marc A. Passman MD, University of Alabama at Birmingham, Birmingham, AL

11:16 am
FDA Requirements for Management of IVC Filters
David L. Gillespie MD, University of Rochester, Rochester, NY

11:24 am
Public and Physician Awareness of Venous Disease
Julianne Stoughton MD, Massachusetts General Hospital, Boston, MA

11:32 am
A New Venous Journal
Anton N. Sidawy MD MPH, George Washington University Medical Center, Washington, DC

11:40 am
Panel Discussion

Attendees will be able to explore the advantages and disadvantages of simulation for open and endovascular procedures; identify areas to focus on for improving skills; and have the opportunity to experience simulation training on less commonly performed procedures. Please note pre-registration is required for this event.

*This program is not eligible for CME credit.

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
2. Identify new technology for diagnosis and treatment of vascular disease.

Moderators:Robert M. Zwolak MD PhD, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Joseph Ricotta, II MD, Emory University School of Medicine, Atlanta, GA

 

1:30 pm
SS6. Long-term Durability of Branched and Fenestrated Endografts
Tara M. Mastracci, Roy K. Greenberg, Matthew J. Eagleton
Vascular Surgery, The Cleveland Clinic Foundation, Cleveland, OH.

1:44 pm
SS7. Results with an Algorithmic Approach to Hybrid Repair of the Aortic Arch
Nicholas D. Andersen, Judson B. Williams, Asad A. Shah, Richard L. McCann, G. Chad Hughes
Duke University Medical Center, Durham, NC.

1:58 pm
SS8. Chimney and Periscope Grafts: Mid-term Results in 77 Consecutive Patients with Complex Aortic Aneurysms
Mario Lachat¹, Felice Pecoraro², Thomas Pfammatter¹, Thomas Frauenfelder¹, Michael Glenck¹, Dominique Bettex¹, Dieter Mayer¹, Zoran Rancic¹, Frank J. Veith^3
1Clinic for Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland; ²University of Palermo, Palermo, Italy; ³New York University Medical Center, New York, NY.

2:12 pm
Video Presentation
VS2. Thoracic Endovascular Aortic Repair with Left Subclavian Artery Laser Fenestration
Sadaf S. Ahanchi, Jean M. Panneton
Department of Surgery Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA.

2:22 pm
Basic Research State-of-the-Art Presentation
SS9. Keeping the Small Aortic Aneurysm Small: The Biology and Science of Medical Management of AAA
John A. Curci
Washington University School of Medicine, Saint Louis, MO.

2:36 pm
SS10. The Sandwich Technique for Hypogastric Endo Revascularization Using Off-the-shelf Devices: 3-year Results
Armando Lobato, Luciana Camacho-Lobato
ICVE, Sao Paulo, Brazil.

2:50 pm
SS11. Management of the Left Subclavian Artery and Stroke After TEVR: Lessons from 1,000 Cases in the MOTHER Registry
Benjamin O. Patterson¹, Peter J. Holt¹, Alan Karthikesalingam¹, Ian M. Loftus¹, Ron M. Fairman², Matt M. Thompson^1
1St. Georges' Vascular Institute, London, United Kingdom; ²Hospital of the University of Pennsylvania, Philadelphia, PA.

3:04 pm
SS12. What is the Fate of Untreated Concomitant Suprarenal Aortic Aneurysms Following EVAR?
Benjamin J. Herdrich, Erin M. Murphy, Grace J. Wang, Benjamin M. Jackson, Ronald M. Fairman, Edward Y. Woo
The University of Pennsylvania School of Medicine, Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, Philadelphia, PA.

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
2. Identify new technology for diagnosis and treatment of vascular disease.

Moderators: John J. Ricotta MD FACS, Washington Hospital Center, Washington, DC
Edward Y. Woo MD, Hospital of the University of Pennsylvania, Philadelphia, PA

4:00 pm
SS13. Obstruction of the Endurant Endograft Post-EVAR; Incidence and Treatment Results
Laura van Zeggeren¹, Joost A. van Herwaarden², Hence J. Verhagen³, Debbie A. Werson¹, Herman J. Zandvoort², Frederico B. Goncalves³, Frans L. Moll², Jean-Paul P. de Vries^1
1Vascular Surgery, St. Antonius Hospital, Nieuwegein, Netherlands; ²University Medical Center, Utrecht, Netherlands; ³Erasmus Medical Center, Rotterdam, The Netherlands.

4:14 pm
Video Presentation
VS3. Removal of Suprarenal Fixing Aortic Stent Graft and In Situ Aorto-Iliac Reconstruction for a Patient with Aortic Stent Graft Infection After EVAR
Young-Wook Kim, Shin-Seok Yang, Yang Jin Park, Keun-Myoung Park, Dong-Ik Kim
Division of Vascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.

4:24 pm
SS14. Comparison of Covered Stents vs. Bare Metal Stents for Treatment of Chronic Atherosclerotic Mesenteric Arterial Disease
Gustavo S. Oderich¹, Luke Erdoes², Christopher LeSar², Peter Gloviczki¹, Audra A. Duncan¹, Manju Kalra¹, Sanjay Misra¹, Stephen Cha¹, Thomas C. Bower^1
1Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN; ²University of Tennessee, Chattanooga, TN.

4:38 pm
SS15. Progress in Management of Visceral Ischemia from Type B Dissections
Colin Ryan, Tara M. Mastracci, Matthew J. Eagleton, Sunita Srivastava, Rebecca Kelso, Sean Lyden, Daniel G. Clair, Timur Sarac
Vascular Surgery, The Cleveland Clinic, Cleveland, OH.

4:52 pm
Video Presentation
VS4. Open Fenestration in a Patient with Acute Complicated Type B Aortic Dissection Involving the Aortic Arch
Ali Azizzadeh, Kristofer M. Charlton-Ouw, Anthony L. Estrera, Hazim J. Safi
University of Texas Houston Medical School, Houston, TX.

5:02 pm
Basic Research State of the Art Presentation
SS16. Advances in Stem Cell Treatment for Wound Healing and Atherosclerosis
Omaida C. Velazquez, MD University of Miami, Miami, FL

6:30 pm - 8:00 pm
Women's Leadership Committee/Young Surgeons Reception
Co-hosted by the Peripheral Vascular Surgery Society Reception
Room: National Harbor 11

6:30 - 8:00 pm
International Guest Reception
Room: Chesapeake 2

Alumni Receptions

6:30 pm - 8:30 pm
Beth Israel Deaconess Division of Vascular Surgery Alumni Reception
Room: Chesapeake 8

6:30 pm – 8:30 pm
Cleveland Clinic Alumni Reception
Room: Chesapeake 4

6:30 pm – 8:30 pm
Emory Vascular Alumni Reception
Room: Chesapeake 5

6:30 pm – 8:00 pm
Henry Ford Hospital Alumni Reception
Room: Chesapeake B

 

6:30 pm - 8:00 pm
Johns Hopkins University Vascular Surgery Alumni Reception
Room: Chesapeake C

6:30 pm – 8:30 pm
Mayo Clinic Alumni Reception
Room: Chesapeake 10

6:30 pm – 8:30 pm
Penn Vascular Alumni Reception
Room: Chesapeake G

6:30 pm - 9:30 pm
UCLA Alumni Reception
Room: Chesapeake 1

6:30 pm – 8:30 pm
University of Washington Vascular Alumni Reception
Room: Chesapeake A

6:30 pm – 9:00 pm
VSB/ABS Reception
Room: Chesapeake 11

Updated May 2012